CORXEL Pharmaceuticals

Corxel Pharmaceuticals is a clinical-stage biopharmaceutical company developing innovative small-molecule therapies for cardiometabolic diseases and acute ischemic stroke, with lead clinical programs in oral GLP-1 therapy for obesity and type 2 diabetes and a thrombolytic/anti-inflammatory agent for acute ischemic stroke.